Skip to content

Dr. Pascale Deryckere

Active
Private limited companyfounded 2004active for 22 yearsBrusselsesteenweg 260, 3090 Overijse, BelgiumKBO/BCE: BE 0865.804.281
Summary

Dr. Pascale Deryckere has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €483,932 and a net result of €55,755. Equity has been growing by about 4.4% per year since 2018. Its solvency ranks better than 41% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 16-06-2004 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.302.040.325 3090 Overijse, since 16-06-2004
Financial year end
31 December
Peppol
Reachable

Board and ownership

Board
  • Deryckere PascaleDirector

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€124,051
▲ 5.9%
Turnover
≈ €230,000
estimated
Profit
€55,755
▲ 0.1%
Equity
€483,932
▲ 13.0%
Total assets
€924,002
▼ 3.4%
  • 2025 accounts filed 18 days after the deadline
Score breakdownlowers riskSector: Human health activities (NACE 86)Size: total assets €924,002Figures for financial year 2025 (filed on 20-08-2026)Liquidity: current ratio 2.24, cash €130,478Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 42% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 77+7
equity 52.4% of total assets
Liquidity 68-1
short-term debt 7.8% · cash 14.1%
Profitability 76=
return on assets 6.0%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025highest value 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026 09-2026: < 0.1%▼ -0.1 percentage points vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value
Credit of up to €45,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.24 (1.62 in 2024), above the usual 1.5. Short-term debt is 7.8% and cash 14.1% of total assets. 47.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 42% of them on solvency, 48% on liquidity, 20% on profitability and 56% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €924,002
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 20-08-2026)
NBB · annual accounts
lowers risk · Liquidity: current ratio 2.24, cash €130,478
NBB · annual accounts
raises risk · 2025 accounts filed 18 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-08-2026, 18 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
18 days late
2024
26 days late
2023
28 days late
2022
28 days late
2021
31 days late
2020
30 days late
2019
1 day early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 23 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 August (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: More equity than 81% of companies in human healthsector median €124,634 · 20,708 companies €483,932 View
  • Positive: 8 profitable years in a rowprofit 2025: €55,755 8 years View

Recent changes

  1. · Gazette deed Company renamed to Dr. Pascale DeryckereChange of role: Deryckere, from statutairezaakvoerder to niet statutairbestuurder
  2. · Gazette deed Incorporation
All 14 events

Comparable companies

These companies have the same main activity as Dr. Pascale Deryckere: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €787,000 and €999,000, founded between 2002 and 2007.

CompanyTotal assetsGross margin
Dr. Pascale Deryckere Overijse€924,002€124,051
DOKTER DEVRIENDT VERONIQUE Halle€838,073€126,832
DOKTER LIEVE CLABOUT Zemst€998,735€124,593
MEDISCH KABINET DR. LUC MOENS Opwijk€841,102€116,120
DR. JOHAN DE SMET Antwerpen€889,244€121,140
DR.YVES HAGERS Koekelare€997,786€135,236
DR MARIANNE LAPORTE Lasne€787,249€129,074
Full comparison

Key facts about Dr. Pascale Deryckere

What is the company number of Dr. Pascale Deryckere?
The company number of Dr. Pascale Deryckere is 0865.804.281. The VAT number is the same number with BE in front: BE 0865.804.281.
Where is Dr. Pascale Deryckere based?
The registered office is at Brusselsesteenweg 260, 3090 Overijse.Company details
What does Dr. Pascale Deryckere do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Pascale Deryckere?
The legal form of Dr. Pascale Deryckere is Private limited company (BV).
When was Dr. Pascale Deryckere founded?
Dr. Pascale Deryckere was founded on 16-06-2004.
Is Dr. Pascale Deryckere still active?
Yes, Dr. Pascale Deryckere is an active enterprise in the KBO register.
What is the turnover of Dr. Pascale Deryckere?
The turnover in financial year 2025 is ≈ €230,000. This figure is estimated from the gross margin of €124,051 and 42 comparable companies (NACE 86220). It probably lies between €200,000 and €300,000.Financials
Is Dr. Pascale Deryckere profitable?
In financial year 2025, Dr. Pascale Deryckere made a profit of €55,755.
Where can I find the annual accounts of Dr. Pascale Deryckere?
Dr. Pascale Deryckere filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Pascale Deryckere due?
Dr. Pascale Deryckere must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.